Close Menu

NEW YORK (GenomeWeb) – Starting April 1, the UK's National Health Service will begin offering Genomic Health's Oncotype DX breast cancer recurrence test to patients who meet certain eligibility criteria.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Sponsored by

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.